Results: 27
Low‐dose rituximab in immune thrombocytopenia: One and done.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 388, doi. 10.1002/ajh.26489
- By:
- Publication type:
- Article
Drug (vaccine)‐induced thrombocytopenia 2021: Diversity of pathogenesis and clinical features.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E162, doi. 10.1002/ajh.26482
- By:
- Publication type:
- Article
Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 491, doi. 10.1002/ajh.26481
- By:
- Publication type:
- Article
Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 431, doi. 10.1002/ajh.26474
- By:
- Publication type:
- Article
TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E159, doi. 10.1002/ajh.26479
- By:
- Publication type:
- Article
Real‐world applicability of commercial chimeric antigen receptor T‐cell therapy among older adults with relapsed and/or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E153, doi. 10.1002/ajh.26472
- By:
- Publication type:
- Article
A 29‐gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 448, doi. 10.1002/ajh.26477
- By:
- Publication type:
- Article
Basiliximab for steroid‐refractory acute graft‐versus‐host disease: A real‐world analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 458, doi. 10.1002/ajh.26475
- By:
- Publication type:
- Article
Health‐related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient‐reported outcomes from the APOLLO trial.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 481, doi. 10.1002/ajh.26480
- By:
- Publication type:
- Article
Single‐dose versus low‐dose rituximab in corticosteroid‐resistant or relapsed ITP: A multicenter, randomized, controlled study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 440, doi. 10.1002/ajh.26473
- By:
- Publication type:
- Article
COVID‐19 vaccines and risks of hematological abnormalities: Nested case–control and self‐controlled case series study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 470, doi. 10.1002/ajh.26478
- By:
- Publication type:
- Article
Serum erythropoietin levels in 696 patients investigated for erythrocytosis with JAK2 mutation analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E150, doi. 10.1002/ajh.26471
- By:
- Publication type:
- Article
Clinical phenotypes of three children with sickle cell disease caused by HbS/Sicilian (δβ)<sup>0</sup>‐thalassemia deletion.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E156, doi. 10.1002/ajh.26470
- By:
- Publication type:
- Article
Sequential next generation sequencing analysis in homogeneously treated low risk NPM1‐mutated acute myeloid leukemia with an adverse clinical outcome.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E135, doi. 10.1002/ajh.26469
- By:
- Publication type:
- Article
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 421, doi. 10.1002/ajh.26463
- By:
- Publication type:
- Article
A population‐based study of acute panmyelosis with myelofibrosis in the United States: 2004–2015.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E144, doi. 10.1002/ajh.26467
- By:
- Publication type:
- Article
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 401, doi. 10.1002/ajh.26466
- By:
- Publication type:
- Article
Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta‐analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 411, doi. 10.1002/ajh.26465
- By:
- Publication type:
- Article
Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experience.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E138, doi. 10.1002/ajh.26464
- By:
- Publication type:
- Article
Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS‐CoV‐2: Results of a prospective study in 150 health professionals in Greece.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E147, doi. 10.1002/ajh.26468
- By:
- Publication type:
- Article
BNT162b2 mRNA SARS‐CoV‐2 vaccination does not cause upregulation of endothelial activation markers or hypercoagulability: A prospective, single‐arm, longitudinal study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E141, doi. 10.1002/ajh.26462
- By:
- Publication type:
- Article
PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 390, doi. 10.1002/ajh.26461
- By:
- Publication type:
- Article
COVID‐19 vaccine response in patients with hematologic malignancy: A systematic review and meta‐analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E132, doi. 10.1002/ajh.26459
- By:
- Publication type:
- Article
Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E129, doi. 10.1002/ajh.26454
- By:
- Publication type:
- Article
Hemophagocytic lymphohistiocytosis, what about hair?
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 508, doi. 10.1002/ajh.26364
- By:
- Publication type:
- Article
Persistent neonatal jaundice resulting from hereditary pyropoikilocytosis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 506, doi. 10.1002/ajh.26358
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 385, doi. 10.1002/ajh.26221
- Publication type:
- Article